his hers semaglutide Hims Inc Hims & Hers Health shares

The proposed clinical trial endpoints are the resolution of steatohepatitis without worsening or liver fibrosis and/or improvement in liver fibrosis one stage or greater without worsening of steatohepatitis

Yet choosing a GLP-1 medication isnt a decision to make on a whim

Code availability All the statistical analyses in this study including propensity-score matching and KaplanMeier Survival analyses were conducted within the TriNetX platform by using its built-in functions

The published Phase 2 data is the practical demonstration that the balance was achieved

W.KennaJ

In a 72-week study, participants experienced an average weight loss of 15-21% when taking different doses of Tirzepatide (5 mg, 10 mg, or 15 mg)